ASH 2021 Highlights
Dana-Farber Cancer Institute faculty highlights from the 63rd Annual Meeting of the American Society of Hematology (ASH).
Blood Cancer Research: Clinical Trial Helps Younger Patient
A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's. Dana-Farber Cancer Institute's Matthew Davids, MD, MMSc, enrolled her on a clinical trial and details the results of that study. The research ...
Director, Clinical Research, Division of Lymphoma Physician
Register for 2021 ASH Highlights CME
As leaders in blood and blood cancer research, physicians and scientists from Dana-Farber Cancer Institute shared advances and insights at the 63rd Annual Meeting of the American Society of Hematology (ASH) on December 11–14, 2021 in Atlanta, Georgia